Table 1.
Data summary from included papers.
Study (Author, Year, Reference) | Country | Number of Patients (Case/Control) | Patient Characteristics (Case) | Mean Age (Case) | Patient Characteristics (Control) | AUC | Mir Fold Increase (Total/STEMI/NSTEMI) | Max Time from Onset Until Sample Acquisition |
---|---|---|---|---|---|---|---|---|
Gidlof, O. et al. 2011 [21] |
Sweden | 9/11 | STEMI Patients Undergoing PPCI | 64.56 ± 2.7 | STEMI/Healthy | 0.859 | 70 | 12 h |
Wang, G-K. et al. 2010 [22] |
China | 33/33 | STEMI and NSTEMI | 63.5 ± 10.1 | AMI/Non-AMI ACS | 0.867 | ____ | 12 h |
Li, Y. et al. 2013 [19] |
China | 67/32 | STEMI (n = 44) and NSTEMI (n = 23) |
63.84 ± 11.17 | AMI/Healthy | 0.947 | 5.67 | 12 h |
Devaux, Y. et al. 2015 [10] |
Czechia, Italy, Poland, Spain, Switzerland | 224/931 | STEMI (n = 45) and NSTEMI (n = 179) |
72 | AMI/Non-AMI ACS | 0.53 | ____ | 12 h |
Wang, R. et al. 2011 [11] |
China | 58/21 | STEMI and NSTEMI | 60.06 ± 11.53 | AMI/non-AMI ACS | 0.89 | 4.4 | 24 h |
Peng, L. et al. 2014 [18] |
China | 76/110 | STEMI (n = 25) and NSTEMI (n = 51) |
64.6 | AMI/non-AMI ACS | 0.912 | 7.26/7.6/7.1 | ____ |
Ji, Q. et al. 2015 [24] |
China | 98/23 | STEMI (n = 77) and NSTEMI (n = 21) |
62.33 ± 13.9 | AMI/Healthy | 0.787 | 15.26/16.65/10.9 | 24 h |
Jia, K.-G. et al. 2016 [17] |
China | 233/146 | STEMI (n = 156) and NSTEMI (n = 77) |
62.32 | AMI/Healthy and Non-AMI ACS | 0.667 | 5.99/6.39/5.18 | 12 h |
Liu, G. et al. 2018 [20] |
China | 145/30 | NSTEMI Patients | 67 | NSTEMI/Healthy | 0.927 | 2.4 | 12 h |
AMI—acute myocardial infarction; STEMI—ST elevation myocardial infarction; NSTEMI—non-ST elevation myocardial infarction; AUC—area under the curve.